الاختبارEN
كل التخصصات

أفضل أطباء - توب -9 أطباء

يلبي المحتوى سياسة التحرير Bookimed ويتم مراجعتها طبياً من قبل
فهد مولود - طبيب عام. حاصل على 4 جوائز علمية. خدم في غرب آسيا. رئيس الفريق الطبي الناطق بالعربية سابقا ومسؤول عن معالجة البيانات ودقة المحتوى الطبي حاليا.
Stephany Ramirez
دكتوراسنان
5سنة خبره ١٦ سنة

Stephany Ramirez

دكتوراسنان
5سنة خبره ١٦ سنة
جمهورية الدومنيكان, سانتو دومينغو
Dystec Dental Clinic
Professor Ismail Aboul Foutouh
اخصائي زراعة الاسنان
29سنة خبره ١٦ سنة
مصر, القاهرة
Bedaya Hospital for IVF and Infertility Treatment

Professor Ismail Aboul Foutouh

اخصائي زراعة الاسنان
29سنة خبره ١٦ سنة
الدكتور البروفيسور إسماعيل أبو الفتوح هو خبير متخصص في العقم وطبيب أمراض النساء بخبرة تزيد عن 20 عاماً. وهو بارع في استئصال الرحم بالمنظار ومتابعة الحمل وجراحة التثدي. أسس مستشفى بداية وكان الرئيس التنفيذي ومؤسس مركز مصر دولي لأطفال الأنابيب.اقرأ المزيد
الدكتور البروفيسور إسماعيل أبو الفتوح هو خبير متخصص في العقم وطبيب أمراض النساء بخبرة تزيد عن 20 عاماً. وهو بارع في استئصال الرحم بالمنظار ومتابعة الحمل وجراحة التثدي. أسس مستشفى بداية وكان الرئيس التنفيذي ومؤسس مركز مصر دولي لأطفال الأنابيب.
اقرأ المزيد
Can Us
جراح اختصاصي تجميل
6سنة خبره ١٦ سنة

Can Us

جراح اختصاصي تجميل
6سنة خبره ١٦ سنة
تركيا, إسطنبول
Esthetic Hospital
Opdr Hasan
أخصائي أمراض الجهاز الهضمي
30سنة خبره ١٦ سنة

Opdr Hasan

أخصائي أمراض الجهاز الهضمي
30سنة خبره ١٦ سنة
تركيا, إسطنبول
Forever Clinica
Bekir Durmush
أخصائي إعادة تأهيل الفم
74سنة خبره ١٦ سنة
4.4
14 تقييمات

Bekir Durmush

أخصائي إعادة تأهيل الفم
74سنة خبره ١٦ سنة
تركيا, إسطنبول
Hermes Clinics
Salih Dc
أخصائي أمراض الجهاز الهضمي
17سنة خبره ١٦ سنة

Salih Dc

أخصائي أمراض الجهاز الهضمي
17سنة خبره ١٦ سنة
تركيا, إسطنبول
Esthetic Hospital
Dr Yalcin Tuzun
اخصائي جلدية
52سنة خبره ١٦ سنة
4.4
14 تقييمات

Dr Yalcin Tuzun

اخصائي جلدية
52سنة خبره ١٦ سنة
تركيا, إسطنبول
Hermes Clinics
Mehdi Afrit
أخصائي أمراض الدم / أخصائي الأورام
13سنة خبره ١٦ سنة
الإمارات العربية المتحدة, الشارقة
Burjeel Specialty Hospital Sharjah

Mehdi Afrit

أخصائي أمراض الدم / أخصائي الأورام
13سنة خبره ١٦ سنة

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

  • Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
  • Breast cancer
  • Solid tumor diagnosis
  • Digestive cancer
  • Gynecological cancer
  • Lung cancer
  • Genitourinary cancer
  • Sarcoma

Awards & Achievements

  • Award from Himaya Foundations and University of Sharjah

Research & Publications

  • Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
  • The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
  • The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
  • The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
  • Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
  • First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21
اقرأ المزيد

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

  • Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
  • Breast cancer
  • Solid tumor diagnosis
  • Digestive cancer
  • Gynecological cancer
  • Lung cancer
  • Genitourinary cancer
  • Sarcoma

Awards & Achievements

  • Award from Himaya Foundations and University of Sharjah

Research & Publications

  • Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
  • The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
  • The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
  • The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
  • Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
  • First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21
اقرأ المزيد
قد تحتوي هذه الصفحة على معلومات تتعلق بمختلف الحالات الطبية والعلاجات وخدمات الرعاية الصحية المتوفرة في بلدان مختلفة. يرجى العلم أن المحتوى مقدم لأغراض إعلامية فقط ولا ينبغي تفسيره على أنه نصيحة أو إرشادات طبية. يرجى استشارة طبيبك أو أخصائي طبي مؤهل قبل البدء أو تغيير العلاج الطبي.